"Health Canada approves Novartis’ Fabhalta for PNH with haemolytic anaemia" was originally created and published by ...

Novartis is expanding its prospects in cardiometabolic disease by striking a deal to acquire Anthos Therapeutics, a company in pivotal testing with a blood clot-preventing drug that could offer ...

Nike returned to the Super Bowl after nearly 30 years with a 90-second spot “So Win” featuring WNBA stars Caitlin Clark, A’ja ...

"Novartis took a risk to really break through ... clinical professor of marketing and co-lead of the school's Ad Review. "The ad started out with a playful tone to then deliver a serious message ...

Novartis has acquired exclusive global rights to GenVec's preclinical hearing loss and balance disorders programme. The programme has been investigating gene therapy to express atonal homologue 1 ...

EVANSTON, Ill., Feb. 9, 2025 /PRNewswire/ -- Novartis took home the top spot in the 21st Kellogg School Super Bowl Advertising Review with its "Your Attention, Please" ad putting a spotlight on ...

To boost its cardiovascular pipeline, Novartis has announced the acquisition of the company it co-founded with Blackstone ...

Swiss pharmaceutical firm Novartis said on Tuesday that it has agreed to buy privately held, clinical-stage US biotech Anthos ...

Deliver returns: Continuing to embed operational excellence and deliver improved financials. Novartis remains disciplined and shareholder-focused in our approach to capital allocation, with ...

"Novartis took a risk to really break through the clutter with its unexpected focus on breast cancer screening," said Tim Calkins, clinical professor of marketing and co-lead of the school's Ad Review ...